Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling

Detalhes bibliográficos
Autor(a) principal: Moreira-Teixeira, Lúcia
Data de Publicação: 2016
Outros Autores: Sousa, Jeremy Nicolas Carvalho, McNab, Finlay W., Torrado, Egídio, Cardoso, Filipa, Machado, Henrique, Castro, Flávia, Cardoso,Vânia, Gaifem, Joana, Wu, Xuemei, Appelberg, Rui, Castro, António G., O’Garra, Anne, Saraiva, Margarida
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/44807
Resumo: Supplementary material: http://www.jimmunol.org/content/suppl/2016/11/12/jimmunol.1600584.DCSupplemental
id RCAP_3dc51f89bd1dd53fad959cf1c02965da
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/44807
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signalingCiências Médicas::Ciências da SaúdeScience & TechnologySupplementary material: http://www.jimmunol.org/content/suppl/2016/11/12/jimmunol.1600584.DCSupplementalTuberculosis causes ∼1.5 million deaths every year, thus remaining a leading cause of death from infectious diseases in the world. A growing body of evidence demonstrates that type I IFN plays a detrimental role in tuberculosis pathogenesis, likely by interfering with IFN-γ–dependent immunity. In this article, we reveal a novel mechanism by which type I IFN may confer protection against Mycobacterium tuberculosis infection in the absence of IFN-γ signaling. We show that production of type I IFN by M. tuberculosis–infected macrophages induced NO synthase 2 and inhibited arginase 1 gene expression. In vivo, absence of both type I and type II IFN receptors led to strikingly increased levels of arginase 1 gene expression and protein activity in infected lungs, characteristic of alternatively activated macrophages. This correlated with increased lung bacterial burden and pathology and decreased survival compared with mice deficient in either receptor. Increased expression of other genes associated with alternatively activated macrophages, as well as increased expression of Th2-associated cytokines and decreased TNF expression, were also observed. Thus, in the absence of IFN-γ signaling, type I IFN suppressed the switching of macrophages from a more protective classically activated phenotype to a more permissive alternatively activated phenotype. Together, our data support a model in which suppression of alternative macrophage activation by type I IFN during M. tuberculosis infection, in the absence of IFN-γ signaling, contributes to host protection.This work was supported by the Fundação para a Ciência e Tecnologia, Portugal, cofunded by Programa Operacional Regional do Norte (ON.2 – O Novo Norte), Quadro de Referência Estratégico Nacional, through the Fundo Europeu de Desenvolvimento Regional (PTDC/SAU-MII/101977/2008 and PTDC/BIA-BCM/102776/2008); by the Francis Crick Institute, which receives its core funding from Cancer Research U.K. (FC001126), the U.K. Medical Research Council (FC001126), and the Wellcome Trust (FC001126); by the U.K. Medical Research Council (MR/U117565642/1); and by the European Research Council (294682-TB-PATH). This work was also supported by Research Grant 2015 from the European Society of Clinical Microbiology and Infectious Diseases (to M.S.). L.M.-T. was funded by the Fundação para a Ciência e Tecnologia (SFRH/BPD/77399/2011) and the European Research Council (294682-TB-PATH). The M.S. laboratory was financed by Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE 2020-Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through Fundação para a Ciência e Tecnologia, Portugal, in the framework of the Institute for Research and Innovation in Health Sciences project (POCI-01-0145-FEDER-007274). M.S. is a Fundação para a Ciência e Tecnologia Associate Investigator. E.T. is a Fundação para a Ciência e Tecnologia Auxiliary Investigator.American Association of ImmunologistsUniversidade do MinhoMoreira-Teixeira, LúciaSousa, Jeremy Nicolas CarvalhoMcNab, Finlay W.Torrado, EgídioCardoso, FilipaMachado, HenriqueCastro, FláviaCardoso,VâniaGaifem, JoanaWu, XuemeiAppelberg, RuiCastro, António G.O’Garra, AnneSaraiva, Margarida20162016-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/44807engMoreira-Teixeira, L., Sousa, J., McNab, F. W., Torrado, E., Cardoso, F., Machado, H., . . . Saraiva, M. (2016). Type i IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-γ signaling. [Article]. Journal of Immunology, 197(12), 4714-4726. doi: 10.4049/jimmunol.16005840022-17671550-660610.4049/jimmunol.160058427849167www.jimmunol.org/cgi/doi/10.4049/jimmunol.1600584info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:48:28Zoai:repositorium.sdum.uminho.pt:1822/44807Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:46:44.378365Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling
title Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling
spellingShingle Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling
Moreira-Teixeira, Lúcia
Ciências Médicas::Ciências da Saúde
Science & Technology
title_short Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling
title_full Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling
title_fullStr Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling
title_full_unstemmed Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling
title_sort Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling
author Moreira-Teixeira, Lúcia
author_facet Moreira-Teixeira, Lúcia
Sousa, Jeremy Nicolas Carvalho
McNab, Finlay W.
Torrado, Egídio
Cardoso, Filipa
Machado, Henrique
Castro, Flávia
Cardoso,Vânia
Gaifem, Joana
Wu, Xuemei
Appelberg, Rui
Castro, António G.
O’Garra, Anne
Saraiva, Margarida
author_role author
author2 Sousa, Jeremy Nicolas Carvalho
McNab, Finlay W.
Torrado, Egídio
Cardoso, Filipa
Machado, Henrique
Castro, Flávia
Cardoso,Vânia
Gaifem, Joana
Wu, Xuemei
Appelberg, Rui
Castro, António G.
O’Garra, Anne
Saraiva, Margarida
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Moreira-Teixeira, Lúcia
Sousa, Jeremy Nicolas Carvalho
McNab, Finlay W.
Torrado, Egídio
Cardoso, Filipa
Machado, Henrique
Castro, Flávia
Cardoso,Vânia
Gaifem, Joana
Wu, Xuemei
Appelberg, Rui
Castro, António G.
O’Garra, Anne
Saraiva, Margarida
dc.subject.por.fl_str_mv Ciências Médicas::Ciências da Saúde
Science & Technology
topic Ciências Médicas::Ciências da Saúde
Science & Technology
description Supplementary material: http://www.jimmunol.org/content/suppl/2016/11/12/jimmunol.1600584.DCSupplemental
publishDate 2016
dc.date.none.fl_str_mv 2016
2016-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/44807
url http://hdl.handle.net/1822/44807
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Moreira-Teixeira, L., Sousa, J., McNab, F. W., Torrado, E., Cardoso, F., Machado, H., . . . Saraiva, M. (2016). Type i IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-γ signaling. [Article]. Journal of Immunology, 197(12), 4714-4726. doi: 10.4049/jimmunol.1600584
0022-1767
1550-6606
10.4049/jimmunol.1600584
27849167
www.jimmunol.org/cgi/doi/10.4049/jimmunol.1600584
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv American Association of Immunologists
publisher.none.fl_str_mv American Association of Immunologists
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133037282197504